US$ 24.19
glp 1 drugs companies GLP-1 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Agonists Weight Loss Drugs
Description
Paccou J, Compston JE

Br J Dermatol (2014) 171(1):15561

Elashoff, M

Available from: www.TANZEUM.com

Having cleared the hurdle as a treatment for diabetes, the FDA then approved semaglutide, marketed as Wegovy, for obesity in 2021, and then in Europe the following year